GRAL compared with ONC: revenue, margins and what each company keeps, and the suppliers and customers both name

GRALGrail, Inc.

Mkt capRevenueRevenue

ONCBeOne Medicines Ltd.

Mkt capRevenueRevenue

Compare

GRALGrail, Inc.

ONCBeOne Medicines Ltd.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

GRALGrail, Inc.

144.20· pre 144.59

Mkt cap$6.4BRevenue$45MQ2 FY26Revenue$147MFY25

ONCBeOne Medicines Ltd.

365.70· pre 370.37· delayed

Pre-marketSep 2 '83

Mkt cap$42.1BRevenue$1.7BQ2 FY26Revenue$5.3BFY25

Compare

Pre-marketSep 2 '83

GRALGrail, Inc.

ONCBeOne Medicines Ltd.

144.20pre 144.59

Price

365.70pre 370.37delayed

$6.4B

Mkt cap

$42.1B

Q2 FY26$45M

Revenue

$1.7BQ2 FY26

FY25$147M

Revenue

$5.3BFY25

GRAL144.20vsONC365.70Pre-marketSep 2 '83

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

GRAL: latest quarter is a loss; flow not drawable.Method ›

Price

rebased to 0%

GRAL, solidONC, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only GRAL 14

AMZNAmazon Web Servicessupplier

DGXQuestsupplier

ILMNIlluminasupplier

TWSTTwist Biosciencesupplier

10 more · GRAL chain ›

Shared 0

No shared counterparties.

Only ONC 4

AMGNAmgensupplier

ZYMEZymeworkssupplier

—Shandong Luye Pharmaceuticalunlistedsupplier

—CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

unlistedsupplier